Clinical Trial Update: Subtyping Primary Aldosteronism With Para-chloro-2-[18F]Fluoroethyl-etomidate [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating para-chloro-2-[18F]Fluoroethyl-etomidate for subtyping primary aldosteronism, currently recruiting at the University Medic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aldosteronism

Drugs mentioned

• para-chloro-2-[18F]Fluoroethyl-etomidate (para-chloro-2-[18F]Fluoroethyl-etomidate)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Primary Aldosteronism | Phase 1, Phase 2 | Status: RECRUITING